Govt, academia and industry collaboration crucial for scientific progress: Dr Jitendra Singh
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
Each company will share operational data with Evinova, feeding the platform’s AI engines to provide benchmarks and actionable insights, aiming to speed up trials while maintaining top-tier patient care
Company to launch product after the expiry of semaglutide patent in India
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Subscribe To Our Newsletter & Stay Updated